📈Specialty drugs are projected to grow by 8% annually until 2025, reshaping the pharmacy landscape. Are you prepared to navigate these shifts? As prices continue to rise, understanding the complexities driving these costs is key. From cancer treatments to autoimmune therapies, some exceed $1 million per year, posing significant challenges for patients and plan sponsors. Chief Pharmacy Officer Mark Campbell, PharmD offers expert strategies for managing costs and ensuring access to vital medications. Dive into the full article on BenefitsPRO for actionable insights: https://rxbene.fit/3Lk6wyI
RxBenefits, Inc.’s Post
More Relevant Posts
-
Founder Director, DoseQuantics Consulting. Consultant in Pharmacokinetics, Pharmacodynamics, Quantitative Pharmacology, Drug Discovery & Development
SILVER JUBILEE OF TRASTUZUMAB [HERCEPTIN] : FLAGSHIP MONOCLONAL ANTIBODY TARGETED DRUG FOR BREAST CANCER From the cloning of the her2 [human epidermal growth factor receptor 2] gene to engineering a humanized antibody that specifically inhibits the HER2 receptor, to approval for treatment of HER2 positive breast cancer (Biomarker based approval), to second generation HER2 therapies, to spur the evolution of ADCs and Bispecific antibodies, Trastuzumab has travelled a long distance in bringing life extending treatments to breast, gastric and lung cancer patients. In 2019, Shepard, Ullrich, and Dennis Slamon, won the Lasker-DeBakey Clinical Medical Research Award for the development of trastuzumab. The Galien Foundation named trastuzumab Best Biotech Product of the Year in 2000 and Best Biotech Product of the Last 50 Years in 2022. https://lnkd.in/gJkRx56q https://lnkd.in/g4-_iWG8
25 Years of Trastuzumab
https://vimeo.com/
-
Oncology Domains For Sale. Common terms that drive traffic to your brand's website. Mind share into market share. BiliaryTract.com ; Epithelioid.com ; HairyCellLeukaemia.com ; IGG4rd.com ; NerveCancer.com ; TesticalCancer.com
-
Still wondering about #theranostics and the impact of this technology for patients? Theranostics, a groundbreaking fusion of "therapy" and "diagnostics," represents a revolutionary approach to personalized medicine. The combination of using one radiopharmaceutical to identify (diagnose) and a second radiopharmaceutical to deliver therapy to treat disease has provided a unique opportunity to craft highly-specific and targeted therapies with high efficacy and great clinical impact for patients. 👉 Learn more about theranostics: #nuclearmedicine #radiopharmaceuticals #iqmedicalservices
PART 1 - What are radiotheranostics for cancer care?
https://www.youtube.com/
-
Positive Quality Interventions (PQIs) are precise and concise peer-reviewed clinical guidance resources. When navigating the intricacies of #oncology treatments, PQIs offer quick and trustworthy insights into drug therapy. Explore our PQI on "Sacituzumab govitecan: Management of Neutropenia and Diarrhea" – a valuable resource for healthcare professionals. This PQI offers essential guidance on managing common adverse events, patient follow-up, and dose modifications related to neutropenia and diarrhea. You can access this resource at the link below: bit.ly/3RnkO5N
-
-
Exciting news! Our anti-phospho-Tau immunotherapy, ACI-35.030, has entered the Phase 2b clinical trial, ReTain, targeting preclinical Alzheimer’s. This major study will assess its impact on cognition and Tau pathology in about 500 participants. #AlzheimersResearch #ClinicalTrials #healthinnovations #precisionmedicine #prevention #alzheimersdisease
We are delighted to announce that our anti-phospho-Tau active immunotherapy ACI-35.030 for Alzheimer’s disease advances into the Phase 2b clinical trial ReTain. This large, potentially registration-enabling study will evaluate the effect of ACI-35.030 on cognition and Tau pathology in approximately 500 participants with preclinical Alzheimer’s disease. AC Immune will now receive a milestone payment of CHF 15 million from its collaboration partner Janssen Pharmaceuticals Inc., a Johnson & Johnson company, and another milestone payment of CHF 25 million related to achieving an enrollment target. https://lnkd.in/eqThQB4e #Alzheimers #immunotherapy #precisionmedicine #prevention
-
-
Oncology Domains For Sale. Common terms that drive traffic to your brand's website. Mind share into market share. WomenInOncology.com; OncologyLeadership.com; Resectable.com; Unresectable.com; TissueIsTheIssue.com
-
Listen Here: https://lnkd.in/g2HeKdRG This episode features bhavesh shah, Chief Pharmacy Officer Specialty and Hematology Oncology Pharmacy at Boston Medical Center (BMC). Here, he discusses his experience staying with the same organization for over 2 decades, trends he is watching in the pharmacy space, health equity initiatives at BMC, and more. For more information about Becker's Healthcare, please contact Jessica Cole or Scott Becker. #podcast #leadership #healthcare #pharmacy
-
Managing numerous clinical sites throughout your trial can be difficult. As your clinical trial partner, Champions Oncology provides custom sample collection kits to ensure your clinical sites have the correct inventory required for your patients. We work with you to determine the best tube types and reagents (evaluated in the development and validation stages) to include in each kit, streamlining the management of your trials’ clinical sites. #clinicaltrial #flowcytometry #customkits #sampleprep
-
-
Varian calls out doing more with less. So how can you leverage your daily tasks to support your Oncology Care at a macro level? Join Inspirata in the upcoming webinar to understand how you can turn cost centers into revenue producing contributors. ⬇️ https://lnkd.in/ezEkiQVm
Oncology staffing shortages are a threat to patient care, and their impact is predicted to increase in coming years. Hear from Head of Clinical Affairs, Dr. Ricky Sharma, on how we can tackle this challenge together. https://bit.ly/3Vajy83
